과제정보
연구 과제 주관 기관 : Tabriz University of Medical Sciences
참고문헌
- Amiri B, Ebrahimi-Far M, Saffari Z, et al (2016). Preparation, characterization and cytotoxicity of silibinin-containing nanoniosomes in T47D human breast carcinoma cells. Asian Pac J Cancer Prev, 17, 3833-6.
- Amirijavid S, Entezari M, Movafagh A, et al (2015). Cytotoxicity effects of mouse IgG produced against three nanoliposomal human DR5 receptor epitopes on breast cancer cells. Asian Pac J Cancer Prev, 17, 257-61.
- Awotwe-Otoo D, Zidan AS, Rahman Z, et al (2012). Evaluation of anticancer drug-loaded nanoparticle characteristics by nondestructive methodologies. AAPS Pharm Sci Tech, 13, 611-22. https://doi.org/10.1208/s12249-012-9782-7
- Bartucci M, Dattilo R, Moriconi C, et al (2015). TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells. Oncogene, 34, 681-90. https://doi.org/10.1038/onc.2014.5
- Beloqui A, Solinis MA, Rodriguez-Gascon A, et al (2016). Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine: NBM, 12, 143-61. https://doi.org/10.1016/j.nano.2015.09.004
- Fujii S, Okinaga T, Ariyoshi W, et al (2013). Mechanisms of G1 cell cycle arrest and apoptosis in myeloma cells induced by hybrid-compound histone deacetylase inhibitor. Biochem Biophys Res Commun, 434, 413-20. https://doi.org/10.1016/j.bbrc.2013.03.043
- Ghanbarzadeh S, Khorrami A, Arami S (2014). Preparation of optimized Naproxen nano liposomes using response surface methodology. J Pharm Investig, 44, 33-9. https://doi.org/10.1007/s40005-013-0098-8
- Han Y, Li Y, Zhang P, et al (2016). Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy. Pharm Dev Technol, 21, 277-81. https://doi.org/10.3109/10837450.2014.996900
- Jiang H, Pei L, Liu N, et al (2016). Etoposide-loaded nanostructured lipid carriers for gastric cancer therapy. Drug Deliv, 23, 1379-82.
- Kazemi S, Sarabi AA, Abdouss M (2016). Synthesis and characterization of magnetic molecularly imprinted polymer nanoparticles for controlled release of letrozole. Korean J Chem Eng, 33, 3289-97. https://doi.org/10.1007/s11814-016-0171-x
- Kuchuk I, Bouganim N, Beusterien K, et al (2013). Preference weights for chemotherapy side effects from the perspective of women with breast cancer. Breast Cancer Res Treat, 142, 101-7. https://doi.org/10.1007/s10549-013-2727-3
- Liu J, Wei T, Zhao J, et al (2016). Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance. Biomaterials, 91, 44-56. https://doi.org/10.1016/j.biomaterials.2016.03.013
- Lu R-M, Chen M-S, Chang D-K, et al (2013). Targeted drug delivery systems mediated by a novel peptide in breast cancer therapy and imaging. PLoS One, 8, e66128. https://doi.org/10.1371/journal.pone.0066128
- Muller RH, Alexiev U, Sinambela P, et al (2016). Nanostructured lipid carriers (NLC): The second generation of solid lipid nanoparticles. in 'percutaneous penetration enhancers chemical methods in penetration enhancement', Eds Springer, 161-85.
- Nair HB, Huffman S, Veerapaneni P, et al (2011). Hyaluronic acid-bound letrozole nanoparticles restore sensitivity to letrozole-resistant xenograft tumors in mice. J Nanosci Nanotechnol, 11, 3789-99. https://doi.org/10.1166/jnn.2011.3871
- Osborne CK, Schiff R (2011). Mechanisms of endocrine resistance in breast cancer. Annu Rev Med, 62, 233. https://doi.org/10.1146/annurev-med-070909-182917
- Patel K, Solanki N, Solanki S (2015). Nanostructured lipid carrier-a novel drug delivery. J Pharm Sci Bioscientific Res, 5, 385-92.
- Prabhakar U, Maeda H, Jain RK, et al (2013). Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res, 73, 2412-7. https://doi.org/10.1158/0008-5472.CAN-12-4561
- Rasaie S, Ghanbarzadeh S, Mohammadi M, et al (2014). Nano phytosomes of quercetin: A promising formulation for fortification of food products with antioxidants. J Pharm Sci, 20, 96.
- Sabzichi M, Samadi N, Mohammadian J, et al (2016). Sustained release of melatonin: A novel approach in elevating efficacy of tamoxifen in breast cancer treatment. Coll Surf B, 145, 64-71. https://doi.org/10.1016/j.colsurfb.2016.04.042
- Selvamuthukumar S, Velmurugan R (2012). Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy. Lipids Health Dise, 11, 1. https://doi.org/10.1186/1476-511X-11-1
- Shao Z, Shao J, Tan B, et al (2015). Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for codelivery of anticancer drugs and DNA. Int J Nanomedicine, 10, 1223. https://doi.org/10.2217/nnm.14.202
- Siddiqa AJ, Chaudhury K, Adhikari B (2014). Letrozole dispersed on poly (vinyl alcohol) anchored maleic anhydride grafted low density polyethylene: A controlled drug delivery system for treatment of breast cancer. Coll Surf B, 116, 169-75. https://doi.org/10.1016/j.colsurfb.2013.12.040
- Tupal A, Sabzichi M, Ramezani F, et al (2016). Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer. J Microencapsul, 33, 372-80. https://doi.org/10.1080/02652048.2016.1200150
- Wicaksono P, Martien R, Ismail H (2015). Formulation and cytotoxicity of ribosome-inactivating protein mirabilis jalapa L. nanoparticles using alginate-low viscosity chitosan conjugated with anti-epcam antibodies in the T47D breast cancer cell line. Asian Pac J Cancer Prev, 17, 2277-84.